Trials / Completed
CompletedNCT01686607
Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40,110 (actual)
- Sponsor
- Astellas Pharma Europe B.V. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This multicenter observational cohort study proposes to establish the risks of short and long-term outcomes in users of parenteral micafungin and in users of other parenteral antifungal agents from 2005 through 2012 with follow-up until 2017.
Detailed description
All eligible patients treated with a parenteral antifungal agent at any time during the years 2005-2012 in each of the participating hospitals, will be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Parenteral micafungin application | Parenteral |
| DRUG | Other parenteral antifungal drugs | Parenteral |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2018-04-30
- Completion
- 2018-04-30
- First posted
- 2012-09-18
- Last updated
- 2024-10-21
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01686607. Inclusion in this directory is not an endorsement.